Statement of Changes in Beneficial Ownership (4)
November 09 2020 - 5:38PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wallace Noel R. |
2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO
[
CL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chairman, President & CEO |
(Last)
(First)
(Middle)
C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/5/2020 |
(Street)
NEW YORK, NY 10022
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 11/5/2020 | | M(1) | | 2977.0000 | A | $61.9300 | 199179.0000 | D | |
Common Stock | 11/5/2020 | | S(2) | | 2578.0000 | D | $84.0388 (3) | 196601.0000 | D | |
Common Stock | 11/6/2020 | | M(1) | | 16008.0000 | A | $61.9300 | 212609.0000 | D | |
Common Stock | 11/6/2020 | | S(2) | | 13898.0000 | D | $83.5035 (4) | 198711.0000 | D | |
Common Stock | | | | | | | | 47684.0000 | I | By Issuer's 401(k) Plan Trustee |
Common Stock | | | | | | | | 335.0000 | I | By Trust |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | $61.9300 | 11/5/2020 | | M (1) | | | 2977.0000 | (5) | 9/10/2021 | Common Stock | 2977.0000 | $0.0000 | 97302.0000 | D | |
Stock Option (Right to Buy) | $61.9300 | 11/6/2020 | | M (1) | | | 16008.0000 | (5) | 9/10/2021 | Common Stock | 16008.0000 | $0.0000 | 81294.0000 | D | |
Explanation of Responses: |
(1) | Exercise of stock options awarded under the issuer's incentive compensation plan. |
(2) | Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. |
(3) | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $84.00 to $84.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(4) | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.50 to $83.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
(5) | Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2015 grant date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Wallace Noel R. C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK, NY 10022 | X |
| Chairman, President & CEO |
|
Signatures
|
/s/ Kristine Hutchinson, Attorney-in-Fact | | 11/9/2020 |
**Signature of Reporting Person | Date |
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Colgate Palmolive (NYSE:CL)
Historical Stock Chart
From Oct 2023 to Oct 2024